Hsbc Holdings PLC Tiziana Life Sciences LTD Transaction History
Hsbc Holdings PLC
- $176 Billion
- Q3 2025
A detailed history of Hsbc Holdings PLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 75,365 shares of TLSA stock, worth $128,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,365
Previous 105,365
28.47%
Holding current value
$128,120
Previous $166,000
4.22%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.06MCall Options Held
32KPut Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI2.74MShares$4.65 Million4.04% of portfolio
-
Marshall Wace, LLP London, X0268KShares$455,6200.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny241KShares$409,3830.0% of portfolio
-
Morgan Stanley New York, NY97.1KShares$165,0730.0% of portfolio
-
Zhang Financial LLC84.2KShares$143,1400.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $174M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...